SYM vs. GNOM

Last updated Jun 4, 2026

SYM (Symbotic Inc) is a stock, while GNOM (Global X Genomics & Biotechnology ETF) is Health & Biotech Equities fund tracking the Solactive Genomics Index. Over the past 5 years, SYM returned 36.45%/yr vs -10.20%/yr for GNOM. At a 0.26 correlation, their price movements are largely independent.

Performance

SYM vs. GNOM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Symbotic Inc (SYM) and Global X Genomics & Biotechnology ETF (GNOM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SYM achieves a -20.66% return, which is significantly lower than GNOM's 7.81% return.

SYM

• 1D: -3.83%
• 1M: -17.18%
• YTD: -20.66%
• 6M: -35.52%
• 1Y: 60.14%
• 3Y*: 12.18%
• 5Y*: 36.45%
• 10Y*: —

GNOM

• 1D: 1.99%
• 1M: 5.82%
• YTD: 7.81%
• 6M: 6.65%
• 1Y: 54.21%
• 3Y*: -0.94%
• 5Y*: -10.20%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

SYM vs. GNOM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
SYM Symbotic Inc	-20.66%	150.95%	-53.81%	329.90%	19.40%	-2.44%
GNOM Global X Genomics & Biotechnology ETF	7.81%	18.65%	-15.99%	-8.63%	-36.27%	-13.18%

Correlation

The correlation between SYM and GNOM is 0.36, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.36
Correlation (3Y) Calculated over the trailing 3-year period	0.37
Correlation (5Y) Calculated over the trailing 5-year period	0.27
Correlation (All Time) Calculated using the full available price history since Mar 10, 2021	0.26

The correlation between SYM and GNOM shifts across timeframes, from 0.26 (all time) to 0.37 (3 years), reflecting how their relationship changes across market environments.

Return for Risk

SYM vs. GNOM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SYM

SYM Risk / Return Rank: 64
SYM Sharpe Ratio Rank: 62
SYM Sortino Ratio Rank: 66
SYM Omega Ratio Rank: 64
SYM Calmar Ratio Rank: 65
SYM Martin Ratio Rank: 61

GNOM

GNOM Risk / Return Rank: 57
GNOM Sharpe Ratio Rank: 60
GNOM Sortino Ratio Rank: 61
GNOM Omega Ratio Rank: 53
GNOM Calmar Ratio Rank: 60
GNOM Martin Ratio Rank: 51

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SYM vs. GNOM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Symbotic Inc (SYM) and Global X Genomics & Biotechnology ETF (GNOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SYM	GNOM	Difference
Sharpe ratio: Return per unit of total volatility	0.67	2.06	-1.39
Sortino ratio: Return per unit of downside risk	1.57	2.91	-1.34
Omega ratio: Gain probability vs. loss probability	1.19	1.33	-0.14
Calmar ratio: Return relative to maximum drawdown	1.29	3.00	-1.71
Martin ratio: Return relative to average drawdown	2.21	8.62	-6.41
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SYM vs. GNOM - Sharpe Ratio Comparison

The current SYM Sharpe Ratio is 0.67, which is lower than the GNOM Sharpe Ratio of 2.06. The chart below compares the historical Sharpe Ratios of SYM and GNOM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	SYM	GNOM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.67	2.06	-1.39
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.35	-0.31	+0.66
Sharpe Ratio (All Time) Calculated using the full available price history	0.33	-0.09	+0.42

Drawdowns

SYM vs. GNOM - Drawdown Comparison

The maximum SYM drawdown since its inception was -72.46%, roughly equal to the maximum GNOM drawdown of -75.00%. Use the drawdown chart below to compare losses from any high point for SYM and GNOM.

Drawdown Indicators

	SYM	GNOM	Difference
Max Drawdown Largest peak-to-trough decline	-72.46%	-75.00%	+2.54%
Max Drawdown (1Y) Largest decline over 1 year	-46.82%	-18.17%	-28.65%
Max Drawdown (3Y) Largest decline over 3 years	-72.46%	-46.47%	-25.99%
Max Drawdown (5Y) Largest decline over 5 years	-72.46%	-72.29%	-0.17%
Current Drawdown Current decline from peak	-45.92%	-55.45%	+9.53%
Average Drawdown Average peak-to-trough decline	-28.01%	-40.55%	+12.54%
Ulcer Index Depth and duration of drawdowns from previous peaks	27.27%	6.30%	+20.97%

Volatility

SYM vs. GNOM - Volatility Comparison

Symbotic Inc (SYM) has a higher volatility of 21.13% compared to Global X Genomics & Biotechnology ETF (GNOM) at 8.47%. This indicates that SYM's price experiences larger fluctuations and is considered to be riskier than GNOM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SYM	GNOM	Difference
Volatility (1M) Calculated over the trailing 1-month period	21.13%	8.47%	+12.66%
Volatility (6M) Calculated over the trailing 6-month period	54.24%	19.44%	+34.80%
Volatility (1Y) Calculated over the trailing 1-year period	90.43%	26.50%	+63.93%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	104.08%	33.57%	+70.51%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	101.73%	34.17%	+67.56%

Dividends

SYM vs. GNOM - Dividend Comparison

SYM has not paid dividends to shareholders, while GNOM's dividend yield for the trailing twelve months is around 1.27%.

Position	TTM	2025	2024	2023	2022	2021	2020
GNOM Global X Genomics & Biotechnology ETF	1.27%	1.37%	0.00%	0.00%	0.00%	0.03%	0.14%
SYM Symbotic Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both SYM and GNOM in my portfolio?

SYM and GNOM have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SYM or GNOM?

SYM has higher volatility (21.13%) compared to GNOM (8.47%). In terms of maximum drawdown, SYM dropped -72.46% vs GNOM's -75.00%.

Which has better risk-adjusted returns?

GNOM currently has the higher Sharpe Ratio (2.06 vs 0.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.